Loading chart...



The current price of HKPD is 0.73 USD — it has increased 4.29
Cellyan Biotechnology Co Ltd is an investment holding company mainly engaged in the over the counter (OTC) pharmaceutical business. The Company mainly provides two services. The supply chain services mainly provide OTC pharmaceutical cross-border e-commerce supply chain services. The procurement and distribution services mainly provide OTC pharmaceutical cross-border procurement and distribution services.
Wall Street analysts forecast HKPD stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for HKPD is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Cellyan Biotechnology Co Ltd revenue for the last quarter amounts to 13.04 USD, decreased -24.10
Cellyan Biotechnology Co Ltd. EPS for the last quarter amounts to USD, decreased
Cellyan Biotechnology Co Ltd (HKPD) has 27 emplpoyees as of April 19 2026.
Today HKPD has the market capitalization of 17.15M USD.